Details for Patent: 10,130,592
Which drugs does patent 10,130,592 protect, and when does it expire?
Patent 10,130,592 protects ADRENALIN and is included in one NDA.
This patent has seven patent family members in seven countries.
Summary for Patent: 10,130,592
| Title: | Epinephrine formulations |
| Abstract: | Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent. |
| Inventor(s): | Vinayagam Kannan, Patrick Irish, Michael Bergren |
| Assignee: | PH Health Ltd |
| Application Number: | US14/863,112 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,130,592 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 10,130,592
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ph Health | ADRENALIN | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 204640-001 | Dec 18, 2013 | AP | RX | Yes | Yes | 10,130,592 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,130,592
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2016233682 | ⤷ Start Trial | |||
| Canada | 2978464 | ⤷ Start Trial | |||
| China | 107614017 | ⤷ Start Trial | |||
| European Patent Office | 3268045 | ⤷ Start Trial | |||
| Japan | 2018507915 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
